Local delivery infusion pressure is a key determinant of vascular damage and intimal thickening

Japanese Circulation Journal

Volumn 62, Issue 4, 1998, Pages 299-304

  Kimura, Tohru ^a   Miyauchi, Katsumi ^a   Yamagami, Shinichiro ^a   Daida, Hiroyuki ^a   Yamaguchi, Hiroshi ^a  

^a JUNTENDO UNIVERSITY   (Japan)

Author keywords

Channeled balloon catheter; Injury; Local delivery; Neointima; Pressure

Indexed keywords

INDOCYANINE GREEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON CATHETER; BLOOD VESSEL INJURY; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DEVICE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; INFUSION SYSTEM; NONHUMAN; RABBIT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANIMALS; CATHETERIZATION; DRUG DELIVERY SYSTEMS; ILIAC ARTERY; RABBITS; TUNICA INTIMA;

EID: 0031952837     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.62.299     Document Type: Article

References (30)

1. Holmes DR Jr, Vlietstra RE, Smith HC, Vetrovec GW, Kent KM, Cowley MJ, et al: Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol 1984; 53: 77C-81C
2. Serruys PW, Luijten HE, Beatt KJ, Geuskens R, de Feyter PJ, van den Brand M, et al: Incidence of restenosis after successful coronary angioplasty: A time-elated phenomenon: a quantitative angiographic study in 342 consecutive patients at 1, 2, 3 and 4 months. Circulation 1988; 77: 361-371
3. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, et al: Restenosis after successful percutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 220 patients. J Am Coll Cardiol 1988; 12: 616-623
4. Califf RM, Fortin DF, Frid DJ, Harlan WR III, Ohman EM, Bengston JR, et al: Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol 1991; 17: 2B-13B
5. Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF: Intimai proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985; 6: 369-375
6. Safian RD, Gelbfish JS, Erny RE, Schnitt SJ, Schmidt DA, Baim DS: Coronary atherectomy: clinical, angiographic, and histological findings and observations regarding potential mechanisms. Circulation 1990; 82: 69-79
7. Ueda M, Becker AE, Tsukada T, Numano F, Fujimoto T: Fibrocellular tissue response after percutaneous transluminal coronary angioplasty: An immunocytochemical analysis of the cellular composition. Circulation 1991; 83: 1327-1332
8. Garrat KN, Edwards WD, Kaufmann UP, Vlietstra RE, Holmes DR Jr: Differential histopathology of primary atherosclerotic and restenotic lesions in coronary arteries and saphenous vein bypass grafts: Analysis of tissue obtained from 73 patients by directional atherectomy. J Am Coll Cardiol 1991; 17: 442-448
9. Steele PM, Chesebro JH, Stanson AW, Holmes DR Jr, Dewanjee MK, Badimon L, et al: Balloon angioplasty: Natural history of the pathophysiological response to injury in a pig model. Circ Res 1985; 57: 105-112
10. Wilentz JR, Sanborn TA, Haudenschild CC, Valeri CR, Ryan TJ, Faxon DP: Platelet accumulation in experimental angioplasty: Time course and relation to vascular injury. Circulation 1987; 75: 636-642
11. Gasperetti CM, Gonias SL, Gimple LW, Powers ER: Platelet activation during coronary angioplasty in humans. Circulation 1993; 88: 2728-2734
12. Casscells W: Migration of smooth muscle and endothelial cells: Critical events in restenosis. Circulation 1992; 86: 723-729
13. Schwartz L, Bourassa MG, Lesperance J, Aldridge HE, Kazim F, Salvatori VA, et al: Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty. N Engl J Med 1988; 318: 1714-1719
14. Ellis SG, Roubin GS, Wilentz J, Douglas JS Jr, King SB III: Effect of 18-to 24-h heparin administration for prevention of restenosis after uncomplicated coronary angioplasty. Am Heart J 1989; 117: 777-782
15. Stone GW, Rutherford BD, McConahay DR, Johnson WL, Giogi LV, Ligon RW, et al: A randomized trial of corticosteroids for the prevention of restenosis in 102 patients undergoing repeat coronary angioplasty. Cathet Cardiovasc Diagn 1989; 18: 227-231
16. The multicenter European Research Trial with Cilazapril After Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group: Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal angioplasty? Results of the MERCATOR study: A multicenter, randomized, double-blind placebo-controlled trial. Circulation 1992; 86: 100-110
17. Wolinsky H, Thung S: Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol 1990; 15: 475-481
18. Goldman B, Blanke H, Wolinsky H: Influence of pressure on permiability of normal and diseased muscular arteries to horseradish peroxidase: A new catheter approach. Atherosclerosis 1987; 65: 215-225
19. Lambert CR, Leone JE, Rowland SM: Local drug delivery catheters: Functional comparison of porous and microporous designs. Coron Artery Dis 1993; 4: 469-475
20. Santoian EC, Gravanis MB, Schneider JE, Tarazona N, Cipolla GD, Robinson KA, et al: Use of the porous balloon in porcine coronary arteries: Rationale for low pressure and volume delivery. Cathet Cardiovasc Diagn 1993; 30: 348-354
21. Nabel EG, Yang Z, Liptay S, San H, Gordon D, Haudenschild CC, et al: Recombinant platelet-derived growth factor B gene expression in porcine arteries induces intimal hyperplasia in vivo. J Clin Invest 1993; 91: 1822-1829
22. Hishikawa K, Nakai T, Marumo T, Hayashi M, Suzuki H, Kalo R, et al: Pressure promotes DNA synthesis in rat cultured vascular smooth muscle cells. J Clin Invest 1994; 93: 1975-1980
23. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, et al: Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model. J Am Coll Cardiol 1992: 19: 267-274
24. Fram DB, Aretz T, Azrin MA, Mitchel JF, Samady H, Gillam LD, et al: Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion. J Am Coll Cardiol 1994; 23: 1570-1577
25. Plante S, Dupuis G, Mongeau CJ, Durand P: Porous balloon catheters for local delivery: Assessment of vascular damage in a rabbit iliac angioplasty model. J Am Coll Cardiol 1994; 24: 820-824
26. Lam JYT, Chesebro JH, Steele PM, Dewanjee MK, Badimon L, Fuster V, et al: Deep arterial injury during experimental angioplasty: Relation to a positive Indium-111-labeled platelet scintigram, quantitative platelet deposition and mural thrombosis. J Am Coll Cardiol 1986; 8: 1380-1386
27. Wolinsky H, Lin CS: Use of the perforated balloon catheter to infuse marker substances into diseased coronary artery walls after experimental postmortem angioplasty. J Am Coll Cardiol 1991; 17: 174B-178B
28. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR: Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res 1990; 67: 651-659
29. Hong MK, Wong SC, Farb A, Mehlman MD, Virmani R, Barry JJ, et al: Feasibility and drug delivery efficiency of a new balloon angioplasty catheter capable of performing simultaneous local drug delivery. Coron Artery Dis 1993; 4: 1023-1027
30. Gunn J, Holt CM, Shepherd L, Grohmann M, Francis SE, Crossman DC, et al: Intra-coronary drug delivery via porous balloon: Local or regional? Circulation 1995; 92(Suppl I): 1-671